Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-02-20 @ 11:30 AM
Study NCT ID:
NCT01957059
Status:
TERMINATED
Last Update Posted:
2017-12-08
First Post:
2013-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)
Sponsor:
BioMarin Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-02
First Submit QC Date:
None
Study First Post Date:
2013-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-06
Last Update Post Date:
2017-12-08
Last Update Post Date Type:
ACTUAL